Mu-Tzu Chu
Impact in
- Pharmacology top 5%
- Drug-Induced Adverse Reactions
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
-
- Drug-Induced Adverse Reactions 5
-
- vaccines and immunoinformatics approaches 2
- Co-authors
- Wen‐Hung Chung (9 shared papers)Wen‐Hung Chung (7 shared papers)Ren‐You Pan (2 shared papers)Shu-Jen Chen (1 shared paper)Lei Zheng (1 shared paper)Wan‐Chun Chang (3 shared papers)Wei-Chi Wang (1 shared paper)Chuang‐Wei Wang (3 shared papers)
- Journals
- Journal of Investigative Dermatology (2 papers)The American Journal of Chinese Medicine (1 paper)Biomedicines (1 paper)Pharmaceutics (1 paper)Journal of Immunology Research (1 paper)
- Partner nations
- TaiwanChinaUnited States
In The Last Decade
Mu-Tzu Chu
9 papers receiving 398 citations
Peers
Comparison fields: 5 of 61
- Pharmacology 185
- Immunology 142
- Rheumatology 94
- Toxicology 16
- Dermatology 32
Countries citing papers authored by Mu-Tzu Chu
This map shows the geographic impact of Mu-Tzu Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mu-Tzu Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mu-Tzu Chu more than expected).
Fields of papers citing papers by Mu-Tzu Chu
This network shows the impact of papers produced by Mu-Tzu Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mu-Tzu Chu. The network helps show where Mu-Tzu Chu may publish in the future.
Co-authors
The 25 scholars most cited alongside Mu-Tzu Chu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 102 | |
| 2 | 2015 | 98 | |
| 3 | 2019 | 89 | |
| 4 | 2019 | 49 | |
| 5 | 2020 | 18 | |
| 6 | 2023 | 17 | |
| 7 | 2022 | 15 | |
| 8 | 2020 | 9 | |
| 9 | 2023 | 8 |
About Mu-Tzu Chu
Mu-Tzu Chu is a scholar working on Pharmacology, Molecular Biology, Oncology, Rheumatology and Immunology, having authored 9 papers that have together received 405 indexed citations. Recurring topics across this work include Drug-Induced Adverse Reactions (5 papers), Immunotherapy and Immune Responses (3 papers), Urticaria and Related Conditions (3 papers), Cancer Immunotherapy and Biomarkers (2 papers), vaccines and immunoinformatics approaches (2 papers), Autoimmune Bullous Skin Diseases (2 papers), CAR-T cell therapy research (1 paper) and Contact Dermatitis and Allergies (1 paper). The work is most often cited by research in Pharmacology (185 citations), Immunology (142 citations), Rheumatology (94 citations), Toxicology (16 citations) and Dermatology (32 citations). Mu-Tzu Chu has collaborated with scholars based in Taiwan, China and United States. Frequent co-authors include Wen‐Hung Chung, Wen‐Hung Chung, Ren‐You Pan, Shu-Jen Chen, Lei Zheng, Wan‐Chun Chang, Wei-Chi Wang, Chuang‐Wei Wang, Chun‐Bing Chen and Elizabeth J. Phillips. Their work appears in journals such as Journal of Investigative Dermatology, The American Journal of Chinese Medicine, Biomedicines, Pharmaceutics and Journal of Immunology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.